Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
| Country | Product | Indication | Sponsor | Date |
|---|---|---|---|---|
|
Cabozantinib | Hepatocellular Carcinoma | Exelixis, Inc.;210 East Grand Avenue;South San Francisco, California, 94083 | March 2, 2017 |
|
Melatonin | Acute acetaminophen overdose | Therapicon SrL;21 Via Malachia Marchesi de Taddei;Milano | March 2, 2017 |
|
Hydroxyurea | Sickle cell anemia | Nova Laboratories Limited;Martin House, Gloucester Crescent;Leicester | March 2, 2017 |
|
3-pentylbenzeneacetic acid sodium salt | Alström syndrome | ProMetic BioTherapeutics, Inc;1330 Piccard Drive, Suite 201;Rockville, Maryland, 20850 | February 28, 2017 |
|
(s)-perillyl alcohol temozolomide carbamate | Intracranially located metastases from breast cancer | NeOnc Technologies, Inc.;8335 Sunset Blvd., #240;Los Angeles, California, 90069 | February 28, 2017 |
|
3-pentylbenzeneacetic acid sodium salt | Alstr�m syndrome | ProMetic BioTherapeutics, Inc;1330 Piccard Drive, Suite 201;Rockville, Maryland, 20850 | February 28, 2017 |
|
Fenfluramine hydrochloride | Lennox-Gastaut syndrome | Zogenix International Ltd | February 27, 2017 |
|
Soluble recombinant human fibroblast growth factor receptor 3 | Achondroplasia | TherAchon SAS | February 27, 2017 |
|
Humanised IgG4 monoclonal antibody to the human toll-like receptor type 2 | Pancreatic Cancer | Opsona Therapeutics Limited | February 27, 2017 |
|
Tauroursodeoxycholic acid | Amyotrophic lateral sclerosis | Bruschettini s.r.l. | February 27, 2017 |
|
Propranolol hydrochloride | Von Hippel-Lindau syndrome | Consejo Superior de Investigaciones Cientificas (CSIC) | February 27, 2017 |
|
Recombinant human club cell 10 KDa protein | Bronchiolitis obliterans syndrome | EUDRAC Limited | February 27, 2017 |
|
Thalidomide | Hereditary haemorrhagic telangiectasia | PlumeStars s.r.l. | February 27, 2017 |
|
Vemurafenib | Erdheim-Chester syndrome | Groupe d'étude des histiocytoses | February 27, 2017 |
|
Adeno-associated virus serotype 2/6 (rAAV2/6) vectors encoding zinc finger nucleases (ZFNs) and the human iduronate 2-sulfatase (hIDS) gene | Hunter Syndrome | Sangamo Therapeutics, Inc.;Point Richmond Tech Center, 501 Canal Boulevard;Richmond, California, 94804 | February 27, 2017 |
|
1-(2,2-difluoro-2H-1,3-benzodioxol-5-yl)-N-{1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl}cyclopropane-1-carboxamide and ivacaftor | Cystic fibrosis | Vertex Pharmaceuticals (Europe) Limited | February 27, 2017 |
|
26 base synthetic single-stranded fully phosphorothioated 2′-O-methyl-RNA and DNA mixmer oligonucleotide-based compound | Dravet Syndrome | Eirgen Pharma Limited | February 27, 2017 |
|
Alpha-tocopherol and ascorbic acid | Fragile X syndrome | Advanced Medical Projects | February 27, 2017 |
|
Autologous T cells transduced with lentiviral vector encoding an anti-SLAMF7 CD28/CD3-zeta chimeric antigen receptor | Multiple myeloma | Dr. Michael Hudecek | February 27, 2017 |
|
Cyclo[L-alanyl-L-seryl-L-isoleucyl-L-prolyl-L-prolyl-L-glutaminyl-L-lysyl-L-tyrosyl-D-prolyl-L-prolyl-(2S)-2-aminodecanoyl-L-alpha-glutamyl-L-threonyl]acetate salt | Primary ciliary dyskinesia | Polyphor UK Ltd | February 27, 2017 |
|
Asciminib | Chronic myeloid leukemia | Novartis Pharmaceuticals Corporation;One Health Plaza;East Hanover, New Jersey, 07936 | February 27, 2017 |
|
Ex-vivo-expanded autologous keratinocytes transduced with retroviral vector containing theCOL7A1gene | Dystrophic epidermolysis bullosa | Abeona Therapeutics Europe SL | February 27, 2017 |
|
Humanised IgG4 monoclonal antibody to the human toll-like receptor type 2 | Myelodysplastic syndromes | Opsona Therapeutics Limited | February 27, 2017 |
|
5-(4,6-dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine | Diffuse Large B-cell Lymphoma | Voisin Consulting S.A.R.L. | February 27, 2017 |
|
Fully human IgG1 antibody specific for CD33 | Myelodysplastic syndromes | Boehringer Ingelheim Pharmaceuticals, Inc.;900 Ridgebury Rd., PO Box 368;Ridgefield, Connecticut, 06877 | February 27, 2017 |
